Pharmacogenomics of Alcohol and Drugs of AbuseAmitava Dasgupta, Loralie J. Langman Pharmacogenomics is the basis of personalized medicine, which is said to be the medicine of the future. Understanding genetic variation in drug and alcohol response is vital for professionals working in rehabilitation programs. The same principles that are applicable for therapeutic drugs are also applicable for drugs of abuse. Pharmacogenomics can |
Contents
Pharmacogenomics Principles of Alcohol and DOA | 1 |
Alcohol Use and Abuse | 11 |
Slate and Trait Markers of Alcohol Abuse | 47 |
Introduction to Drugs of Abuse | 93 |
Pharmacogenomics of Amphetamine and Related Drugs | 129 |
Pharmacogenomics of Cocaine | 137 |
Genetic Aspect of Marijuana Metabolism and Abuse | 155 |
Genetic Aspect of Opiate Metabolism and Addiction | 165 |
Pharmacogenomics Aspects of Addiction Treatment | 195 |
Methodologies in Pharmacogenetics Testing | 211 |
Back Cover | 229 |
Other editions - View all
Pharmacogenomics of Alcohol and Drugs of Abuse Amitava Dasgupta,Loralie J. Langman Limited preview - 2012 |
Pharmacogenomics of Alcohol and Drugs of Abuse Amitava Dasgupta,Loralie J. Langman Limited preview - 2012 |
Pharmacogenomics of Alcohol and Drugs of Abuse Amitava Dasgupta,Loralie J. Langman No preview available - 2019 |
Common terms and phrases
acid activity addiction alco alcohol abuse Alcohol Clin Exp alcohol dependence alcohol-related allele amphetamine Anal Toxicol analgesic analysis assay associated with alcohol BChE behavior benzodiazepines Biol blood alcohol brain buprenorphine cancer Clin Exp Res Clin Pharmacol clinical cocaine codeine concentrations consumed detection disorders dopamine receptor dose DRD2 drinkers drugs of abuse effects enzyme ethanol fentanyl function GCMS genome genome-wide genotype haplotype heroin human hydrocodone hydromorphone immunoassay increased ingestion inhibition interactions LCMSMS levels liver marijuana Markers of Alcohol mass spectrometry MDMA medications metabolism metabolites methadone methamphetamine method moderate alcohol consumption monoamine morphine naltrexone neurons neurotransmitter ng/mL nicotine oligonucleotide opiate opioid receptor OPRM1 oral fluid oxycodone oxymorphone pathways patients pharmacogenetics plasma polymorphism potential primer probes protein Psychiatry receptor gene reduced risk of developing role samples sequence serotonin transporter serum single nucleotide polymorphisms specific syndrome target testing tion toxicity tramadol treatment response urine variants wine